Sign in
TerminatedNo phase

Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

Key facts

Who runs it
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Where
Pittsburgh, United StatesSee the site
Trial code
Status
Terminated
People taking part
2 people enrolled
Started
24 Aug 2022
Ended
21 Feb 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Baseline (or standard of care) DBS programming
  • Burst-type DBS electrical stimulation programming
Record updated
28 May 2025
Why it stopped
Recruitment Challenges due to the reluctance of patients who have achieved successful outcomes with their DBS and hesitation to change their device settings.

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Bilateral DBS-STN (subthalamic nucleus) target for idiopathic Parkinson's disease implanted minimum 6 months prior to the day of study enrollment
  • Stable DBS programming settings and Parkinson's disease medications defined as no changes to either within past 2 weeks
  • Comfortable using DBS controller to turn off device prior to study visits
  • Able to provide informed consent and complete follow-up visits

Who cannot take part

  • DBS technology other than Boston scientific Genus/Gevia
  • Unable to complete follow-up visits
  • DBS brain targets other than STN (subthalamic nucleus)
  • Signs of progressive cognitive decline

Where in United States

  • AHN Allegheny General HospitalPittsburgh, United States

About the trial

What the trial wants to find out

This is a study to evaluate Deep brain stimulation (DBS) burst-type electrical stimulation programming verses standard DBS programming. Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional high-frequency rectangular wave stimulation are delivered. Burst type DBS may improve the efficacy and durability of DBS pulse generator.

The 2 groups in the trial

  • Baseline Programming First, Then Experimental Burst-type ProgrammingTreatment being tested

    In this arm, patients were randomized to initially receive treatment with baseline DBS programming (standard of care) at Visit 1. After a 30 minute treatment period, patients were to undergo UPDRS III evaluation, a 15 minute washout period with the DBS turned off and then experimental Burst-type programming for 30 minutes. Finally, patients were to undergo UPDRS III evaluation after the second round of programming.

    Treatment: Baseline (or standard of care) DBS programming and Burst-type DBS electrical stimulation programming

  • Experimental Burst-type Programming First, Then Baseline ProgrammingTreatment being tested

    In this arm, patients were randomized to initially receive treatment with experimental Burst-type DBS programming at Visit 1. After a 30 minute treatment period, patients were to undergo UPDRS III evaluation, a 15 minute washout period with the DBS turned off and then baseline programming (standard of care) for 30 minutes. Finally, patients were to undergo UPDRS III evaluation after the second round of programming. Burst-type DBS is defined as a novel stimulation protocol in which intermittent bursts of traditional high-frequency rectangular wave stimulation are delivered.

    Treatment: Baseline (or standard of care) DBS programming and Burst-type DBS electrical stimulation programming

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Burst-Type Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Pilot Study of Tolerability and Efficacy
Record updated
28 May 2025